For years, advisers have told pharma clients that it is hard to find an example of reputation problems affecting the bottom line: the purchasing process is so complex (doctor – pharmacist – patient with insurers and wholesalers in the mix) that reputation worries don’t seem to hit sales. Ranbaxy might be disproving all the articles and lectures on … [Read more...] about Indian patients demand non-Ranbaxy medicines
A fascinating piece in the current edition of Foreign Affairs (the summary is here http://fam.ag/10MY53A but you need a subscription to read it). The author thinks that India does not have a coherent foreign policy and that most decisions are made by highly autonomous senior Indian Foreign Service officers. There are weaknesses in her methodology … [Read more...] about Is The Indian foreign policy too feeble to let it lead?
Every year, Mark Chataway (of Hyderus) writes a piece for Pharmaceutical Executive. This year's piece is on how badly the pharmaceutical industry does with social media (and is co-written with James Ward). It's already proving highly controversial. "Pharma wants to play the role of a second-grade consumer marketer, not that of a thoughtful … [Read more...] about Pharmas intimacy problem with social media
There is a collective denial amongst many foundations and NGOs about what will happen to overseas development assistance (ODA) from Europe. Three trends mean that old-fashioned aid is under threat as never before The economy, stupid. Government spending is under immense pressure in Europe, the USA and some other industrialised economies. … [Read more...] about Bleak outlook for development assistance in 2012
THE WAY OUT OF THE MAZE FOR THE PHARMACEUTICAL INDUSTRY The pharmaceutical industry faces an uncertain future. Prices, intellectual property and marketing freedom are under assault across the world. Even in the U.S, by far the world’s largest pharma market, the industry is fighting a furious rearguard action against Canadian imports, changes to … [Read more...] about The way out of the maze for the pharmaceutical industry
WHY AGENCY PITCHES ARE A BAD IDEA Of course, being drop-dead gorgeous and almost terminally charming, I think agencies should be chosen for having pretty people who are good fun. And it’s easy too – just go for a drink with them, somewhere well-lit, and you can decide who you want to work with. There are two drawbacks to this tried and true … [Read more...] about Let us have an agency pitch
“This one time, I was in a meeting of African health ministers, and they were being lectured by a group of very well-meaning Europeans and Americans (who, by the way, are very keen on lecturing Africans in general). Finally, the health minister of Cote-d’Ivoire (Ivory Coast) had had enough of this,” Mark chuckles, “so he stood up and said, ‘It … [Read more...] about A Development Dilemma
Portugal is poised for a general strike to protest the austerity measures. Athens is cleaning up. British civil servants have been told that they can’t travel first class on the railways even if they use their own money to upgrade because it would send the wrong message. Across Europe (with the perennial exception of France), we are entering an age … [Read more...] about How come people in international development have not noticed the age of austerity?
The shelves in the government goody store are about to become a lot more bare. How will the kids cope? Those of us who try to change policy are a bit like a group of children at the sweet shop. We look at the shelves, pester our parents for money, try to do deals with our friends to maximise our purchasing power or, more often, to stop the … [Read more...] about Lessons from the candy store and the playground: how to defend government spending in hard times